A recent study has demonstrated that YB-1, a ILF2 interacting protein, regulates liver lipid metabolism by regulating the Wnt/β-catenin signaling pathway 49, which implied the possibility of ILF2 in the regulation of NAFLD. The gene discussed is ILF2; the disease is metabolic dysfunction-associated steatotic liver disease.